T lymphocytes cultured from a patient (T.D.) with adenosine deaminase (ADA) deficiency expressed ADA activity in the normal range, inconsistent with her severe immunodeficiency, metabolic abnormalities, and with the absence of ADA activity in her B lymphocytes and other nucleated hematopoietic cells.
Introduction
The majority of individuals with inherited deficiency of adenosine deaminase (ADA),' probably over 200 since the first report (1) , have cellular immune dysfunction, usually with the 1. Abbreviations used in this paper: ADA, adenosine deaminase; ASO, allele-specific oligonucleotide; PCR, polymerase chain reaction; PEG-ADA, polyethylene glycol modified ADA; PNP, purine nucleotide phosphorylase; SCID, syndrome of combined immunodeficiency.
syndrome of combined immunodeficiency (SCID) (2, 3). About 10 healthy individuals, identified through screening, have had normal immune function (4) (5) (6) (7) (8) (9) (10) (11) (12) . Both groups lack ADA activity in erythrocytes, but whereas the former also has . 1% of normal activity in blood mononuclear cells and B cell lines (complete deficiency) (6, 9, 10, 13) , the latter has 4-70% of normal activity (partial deficiency). Structural gene mutations, which presumably diminish enzyme stability or catalytic activity to different extents, occur in both groups (14) (15) (16) (17) (18) (19) (20) (21) . The degree of ADA deficiency determines the severity of toxic effects of deoxyadenosine, including dATP pool expansion and inactivation of S-adenosylhomocysteine hydrolase. Profound T cell depletion, the hallmark of complete ADA deficiency, has been attributed to sensitivity ofthis lineage to dATP accumulation (reviewed in reference 3). The fact that relatively little residual ADA activity prevents metabolic disturbances and preserves cellular immunity in partial deficiency has encouraged development of methods for treating immunodeficient patients by enzyme replacement or by inserting a functional ADA gene into stem cell progenitors of T cells.
In the context of present understanding of the molecular and clinical heterogeneity of ADA deficiency, we report an unexpected observation: the expression of high levels of ADA activity in cultured T cells of a patient with SCID, whose other hematopoietic cells express levels typical of complete enzyme deficiency.
Methods
Materials. Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) was obtained from Burroughs Wellcome Co. (Research Triangle Park, NC), [8-'4C] Enzyme assays. Nucleated cells (0.2-2 X 106) were lysed by three cycles of freezing and thawing in 0.15 ml of 10 mM Tris-HCI, pH 7.4, and 1 mM EDTA. After centrifugation for 2 min in a microcentrifuge, 0.1 ml of supernatant was passed over Sephadex G-25 equilibrated with 25 mM Tris-HCl, pH 7.4, 15 mM KCI, 1 mM EDTA, and I mM dithiothreitol using the "spun-column" technique (24). ADA activity was assayed (25) using 150 MM [14C]adenosine (20, ,000 cpm/ nmol) and purine nucleoside phosphorylase (PNP) (26) using 100 IM
[14C]inosine (20, ,000 cpm/nmol). After incubation at 370C, 5
,ul of 50-ML reactions were spotted with unlabeled ultraviolet (UV) markers on cellulose thin layer plates (PolygramCel 400 UV250; Macherey-Nagel, Duiren, FRG), which were developed in 1% Tris base (ADA) or water (PNP). ADA in cell extracts was analyzed by electrophoresis on cellulose acetate strips (Helena Laboratories, Beaumont, TX) in 0.1 M sodium phosphate, pH 6.5; in situ staining for ADA was modified from the method of Spencer et al. (27) . Protein was determined (28) using BSA as standard.
Surface antigen and HLA phenotyping. Expression of cell surface antigens was analyzed by indirect immunofluorescence and FACS of 10,000 cells on an EPICS 753 flow cytometer (Coulter Electronics Inc., Hialeah, FL) (29, 30) . Sorting of T cells into CD4+ and CD8+ populations was performed as described (31 4 and at 450C for the exon 7 ASO with the same solution containing 1.5 X 107 cpm/ml of ASO that had been 5' end labeled with [32P]ATP (3,000 Ci/mmol). Hybridization conditions were determined as previously described (35, 36) . Membranes were washed in 2X SSC and 0.1% SDS for 15 min at 450C for both mutant ASO, and for 20 min at 450C for both wild-type ASO. Washed membranes were exposed to x-ray film (X-omat RP; Eastman Kodak Co., Rochester, NY) between intensifying screens for 5-16 h at -70'C. Aliquots of cloned and reamplified DNA (one-tenth of PCR reaction mixtures) were electrophoresed in quadruplicate 0.8% agarose gels and transferred to ZetaProbe membranes (Bio-Rad Laboratories, Richmond, CA). Each membrane was probed with one of the four ASO as described above.
Northern analysis. Total cellular RNA (35 Mg) from T and B cells (34) was electrophoresed in a 1% agarose-37% formaldehyde gel, transferred to a Hybond-N membrane (Amersham Corp., Arlington Height, IL), and prehybridized in a solution containing 50% formamide, SX Denhardt's solution, 0.1% SDS, SX SSC, and 150 Mg/ml denatured salmon sperm DNA at 42°C. Hybridization was carried out overnight at 42°C with I07 cpm 32P-labeled, heat-denatured DNA probes in prehybridization solution. The membrane was then washed to a stringency of0. IX SSC, 0.1% SDS at 65°C. Probe for ADA mRNA was prepared from pADA21 1(37), provided by J. Hutton, University of Cincinnati; probe for S-adenosylhomocysteine hydrolase was prepared from pDEC16-1 (38 Filters were washed to a stringency of 0.1X SSC, 0.1% SDS at 65°C, and exposed to x-ray film at -70°C.
Patient. T.D. developed SCID before age 3 mo and was found to be ADA deficient; her erythrocyte dATP was 1 ,100 nmol/ml packed cells vs. < 20 nmol/ml in healthy patients with partial ADA deficiency (40) . A B cell line from T.D., GM 2606, had < 0.5% ofnormal ADA activity (6) . T T.D. showed several characteristics of authentic ADA,-including the same electrophoretic mobility (Fig. 2) ; a Km for Ado of 35 MM (Fig. 3 A) human T and B cell lines (Fig. 3 B) . The are shown (Fig. 4) . T.D. was heterozygous at each locus; band patterns from her T and B cells were identical and quite differ-4-Deficient, ent from an unrelated control. For pXg3, a parent of the patient was also tested, and was found to share one allele with T.D.-derived T and B cells (Fig. 4 B) (39) . Thus, the cumulative probability of false association in the present case is 10-9-10-'o. allele, and G727 -A (exon 7) changing Arg211 to His in the other. We tested for these mutations by hybridizing radiolabeled ASO to DNA spanning basepairs 219-846, which was amplified from first strand ADA cDNA prepared from T.D. T cell clones IF12 (ADA') and 4F1 1 (ADA-) (see Table I ).
Uncloned, amplified cDNA from T.D. T cells gave positive signals under stringent conditions with both wild-type and mutant ASO at both mutation sites; amplified cDNA from normal T cells reacted only with the wild-type ASO (Fig. 5 A) . The amplified ADA cDNAs were subcloned and analyzed with ASO to determine the phase of wild-type (wt) and mutant (mut) sequences on individual alleles. Of seven cloned cDNAs from IF12 cells (ADA'), two showed an exon 4mut/exon 70t pattern and five an exon 40'/exon 7mut pattern ( Fig. 5 B) ; similarly, with 4F1 1 cells (ADA-) 4 of 11 cloned cDNAs showed the former and 7 the latter pattern (Fig. 5 C) . None of the subcloned cDNAs from either T cell clone showed a double mutant pattern or the double wild-type pattern of control T cells. Levels oftotal ADA mRNA were similar in ADA' T cells (clone IF12) and ADA-B cells from T.D., as were levels of mRNA for S-adenosylhomocysteine hydrolase (Fig. 5 D) . The latter was used as an internal control because its gene, like that for ADA, is located on the long arm of chromosome 20 (46, 47 Besides lacking ADA activity (6, 10, 13, and present studies), GM 2606 cells have been found to express normal or three-to fourfold increased levels of ADA mRNA (37, 48, 49) , but barely detectable ADA protein, estimated at -10% (13) and 0.35% (10) of normal. GM 2606 mRNA could be translated in vitro into normal-sized ADA protein (50) , but when introduced into fibroblasts cDNAs containing each of the GM 2606 ADA mutations (Argo1--'Trp, Arg21,,-*His) induced a 15-25-fold increase in ADA mRNA but no increase in ADA activity, while wild-type cDNA induced a 25-fold increase in ADA activity (18 Despite the ability of her T cells to express high levels of ADA activity in vitro, we have seen no evidence of ADA ex-
